Get started

Earnings

SentinelOne Looks Like Palantir Before The BreakoutIn every market cycle, some high-growth companies are misunderstood—until they aren’t. Palantir (PLTR) was one such stock, dismissed early for its lack of profitability and complex model, only to soar when its AI tools gained traction. Now, SentinelOne (NYSE: S) may be next in line. 🧠 What SentinelOne Does SentinelOne is a top-tier cybersecurity firm offering an AI-powered endpoint protection platform called Singularity. Like Palantir, SentinelOne has faced criticism for: Persistent losses High stock-based compensation (SBC) A misunderstood business model Despite this, its technology is sticky, deeply embedded in client IT systems, and well-positioned to ride macro trends in AI and cybersecurity. 📈 Financials: Turning a Corner While the stock hasn’t moved much in two years, trading around $18, SentinelOne’s fundamentals are improving: Revenue Growth: Double-digit YoY revenue growth (23%+ in each of the last 10 quarters) Free Cash Flow: $214 million in the past 12 months (~25% FCF margin) Gross Margins: High and improving Operating Expenses: Slowing, creating operating leverage Adjusted Earnings: Near breakeven, signaling profitability is in reach These trends mirror Palantir’s path before its breakout, particularly the shift from high OpEx to better margins and rising free cash flow. 💰 Valuation: Still Underrated SentinelOne is trading at only 6x sales and 27x free cash flow, despite: Strong 20%+ expected revenue growth Analyst EPS estimates of ~$0.50 by 2028 A market cap under $6 billion It’s significantly cheaper than peers like CrowdStrike and Palo Alto Networks—despite having similar growth and margin profiles. ⚠️ Risks to Consider Fierce Competition: Cybersecurity is a crowded field. SentinelOne will have to keep innovating to stay relevant. Market Sentiment: As a high-growth name, it may be hit hard in downturns. Limited TAM vs. PLTR: The cybersecurity market isn’t as vast as AI data platforms. 🚀 Final Take With strong recurring revenue, improving profitability, and an attractive valuation, SentinelOne looks poised for a re-rating. While it may not match Palantir’s scale or splash, the setup is strikingly similar. Rating: Strong Buy
NYSE:SLong
by PropNotes
How We're Earning A 13%+ Yield Selling Puts On Rocket LabThe commercial space sector is booming, and Rocket Lab NASDAQ:RKLB stands out as one of the most promising players—not just another speculative startup or space tourism hype. But while the company is making strong operational strides, its stock valuation appears stretched, prompting a more strategic approach to investing. 📈 Strong Execution, Growing Opportunity Rocket Lab continues to hit meaningful milestones. In Q1, the company: Secured a U.S. Space Force contract for its upcoming Neutron heavy-lift rocket. Won hypersonic-related contracts with the U.S. Air Force and the U.K. Ministry of Defense. Successfully completed five Electron rocket launches and booked eight more. Made a strategic acquisition for developing "Flatellites," enhancing vertical integration. Revenue rose 32% year-over-year, with gross margins in the mid-30% range. Importantly, Rocket Lab has a $1 billion+ revenue backlog, with over half expected to convert in the next year, and a healthy mix of government and commercial clients across both its Launch and Space Systems divisions. 💰 Valuation: Big Potential, Bigger Price Tag Rocket Lab's business is solid, but its valuation raises red flags. With a price-to-sales ratio near 55x (compared to SpaceX's ~14x), investors are paying a steep premium for future success. The company is still unprofitable, and the high valuation leaves little room for error. Simply put, the market may be rewarding Rocket Lab too early. 📊 The Smarter Move: Sell Put Options Instead of buying shares at inflated levels, the better approach is to sell put options—a strategy that earns upfront cash and offers the opportunity to buy shares at a discount if the stock drops. Recommended trade: Sell October 17th $30 strike put options Premium: ~$96 per contract Required buying power: ~$2,904 Implied return: ~3.3% over 90 days, or ~13.4% annualized This provides income now, while still giving investors potential exposure to Rocket Lab at a 40% discount to current prices. ⚠️ Risks to Consider This isn’t risk-free. If Rocket Lab’s execution falters—especially with Neutron—shares could drop sharply. Selling puts means you may still be forced to buy at $30, even if the stock falls much lower. This strategy works best for investors comfortable owning RKLB long term at a lower entry price. ✅ Bottom Line Rocket Lab is a strong business, but the stock looks overheated. Selling put options offers a more balanced way to participate in its growth story—earning income now while positioning to buy the stock later at a better value. Rating: Buy (via options strategy)
NASDAQ:RKLBLong
by PropNotes
Why We See 100%+ Upside In SoFi Over The Next 3 YearsAfter soaring to nearly $28 per share during the SPAC-fueled fintech boom in 2021, SoFi Technologies (SOFI) crashed back to earth, trading under $5 as rising interest rates, regulatory headwinds, and lack of profitability dimmed investor optimism. But the tide has turned. Over the past year, SoFi has reshaped its business and posted significant growth. Shares are now up 247% since our previous bullish call at $6. With the company now profitable and diversifying revenue, we'd argue there’s still upside ahead. 💼 A Stronger, Diversified Business SoFi has evolved from a student loan-focused lender into a full-spectrum fintech platform. It now operates across: Lending: $413M in Q1 revenue Financial Services (consumer banking): $303M Technology Platform (B2B): $103M While lending still makes up the majority, the tech and services segments are growing fast—especially financial services, which doubled revenue YoY and tripled profit. SoFi's white-label platform also gives it a SaaS-like recurring revenue profile. Q1 results showed: Revenue: $770M (+33% YoY) EPS: $0.06, with a $31M revenue beat This business mix gives SoFi more stability and better scalability than many traditional financial firms. 💰 Valuation: Pricey vs. Banks, Cheap vs. Fintech Critics point to SoFi’s rich valuation—trading at over 8x sales—as a concern. But when compared to other fintechs like NuBank (12x sales) and Robinhood (28x), SoFi looks much more reasonably priced. On a forward earnings basis, SoFi trades at ~32x GAAP EPS, and if growth continues, this could drop below 30x. That’s appealing for a company expected to grow: Revenue: ~25% annually Net income: ~33% annually By 2027, analysts project $1B in operating income, double today’s figure. If SoFi maintains current valuation multiples, this alone could double the stock in 3 years. ⚠️ Risks to Watch Regulatory scrutiny in the financial sector Cyclicality of consumer lending Intense competition from firms like Robinhood, Chime, and Coinbase Despite these challenges, SoFi’s expanding ecosystem and growing brand strength position it well. ✅ Final Take: Still a 'Strong Buy' With accelerating revenue, expanding margins, and a scalable business model, SoFi has moved beyond its hype-fueled origins and is now a real fintech contender. Even after its rally, its valuation still leaves room for meaningful upside. Rating: Strong Buy
NASDAQ:SOFILong
by PropNotes
EOY based on yesterday's earnings and the flywheel effect# Alphabet's Accelerating Flywheel: Q2 2025 Earnings Validate the Strategy technicals grounded in an anchored pitchfork hinged on the pre-covid levels (covid bottom just makes the path too aggressive for EOY) and fib retracements of the 2022 bear market decline. General and simple targets since moving averages aren't providing much clarity. Single stock analysis is even more voodoo than large sector indexes, so I'll focus on fundamentals instead: ## The Flywheel In Action: Q2 2025 Results Alphabet's blowout Q2 2025 earnings provide concrete evidence that their integrated AI flywheel is already spinning faster. **Revenue grew 14% to $96.4 billion, crushing expectations**, while the company raised its 2025 capital expenditures from $75 billion to **$85 billion**—a bold investment that initially spooked some investors but actually signals the flywheel's acceleration. ### Why the $85 Billion Capex Increase is Strategic Genius The additional $10 billion isn't just spending—it's **strategic reinvestment in the flywheel's core components**: **Infrastructure Dominance:** Google Cloud revenue surged 32% to $13.6 billion, now approaching a $50+ billion annual run rate. The capex increase funds the massive data centers and TPU clusters needed to serve exploding AI demand. **Competitive Validation:** Even OpenAI, Google's biggest AI rival, is now renting Google's TPU chips to power ChatGPT—choosing Google's proprietary hardware over Nvidia GPUs for cost-effective inference. This partnership alone validates the integrated hardware-software advantage. **Market Leadership:** With AI Overviews reaching 2+ billion users (up from 1.5B last quarter) and Gemini hitting 450+ million users, Google is proving it can deploy AI at unprecedented scale while generating immediate revenue. ## The Core Flywheel System **The Engine:** World-class AI research (DeepMind, Google AI) creating increasingly capable models that serve as tools for invention, not just products. Gemini's rapid user growth proves the models are competitive. **The Fuel:** Search and YouTube revenue provides patient capital for long-term moonshots, while diverse data from billions of users continuously improves AI models. Q2's strong advertising performance ($64B+) funds the entire system. **Custom Hardware Advantage:** Proprietary TPUs optimized for their AI software create faster, more efficient training and inference than competitors using general-purpose chips. OpenAI's adoption proves TPUs offer superior cost-performance. **The Multiplier:** Quantum computing research that could eventually solve problems impossible for classical computers, creating step-change advantages in materials science and optimization. ## AI Integration Across the Ecosystem: The Ultimate Moat Alphabet's true competitive advantage lies in **embedding AI across their existing billion-user platforms**, creating compound defensibility: **Search Dominance:** AI Overviews now appear in 2+ billion monthly searches across 200+ countries, fundamentally changing how users interact with information while maintaining Google's search monopoly. Users increasingly expect AI-powered results, making switching costs even higher. **Productivity Lock-in:** Gmail's Smart Compose, Google Docs' AI writing assistance, and Sheets' intelligent data analysis create sticky enterprise and consumer habits. Once teams adopt AI-enhanced workflows in Google Workspace, migration becomes exponentially more difficult. **Developer Ecosystem:** Google's coding tools (Colab, Android Studio) now feature AI pair programming, while languages like Go and Dart benefit from AI-optimized development. This creates a generation of developers trained on Google's AI tools. **Educational Moat:** Chromebooks in schools now include AI tutoring and personalized learning, creating habits among students who will become tomorrow's decision-makers. Google for Education's AI features make alternative platforms seem primitive. **Entertainment Integration:** YouTube's AI-powered recommendations, creator tools, and content moderation have become so sophisticated that creators and viewers alike can't imagine the platform without them. This strengthens YouTube's dominance over TikTok and other competitors. **Mobile and Browser Dominance:** Android and Chrome's AI features (Smart Reply, intelligent autofill, predictive text) create seamless experiences that competitors struggle to match without Google's data advantages. ## Near-Term Flywheel Accelerators **Physical AI & Robotics:** Moving from digital-only AI to robots that can perceive and manipulate the physical world. Waymo has now driven 100+ million autonomous miles, generating unique physical-world training data. **AI Biology:** DeepMind's protein folding breakthroughs and Isomorphic Labs' drug discovery pipeline could create massive pharmaceutical revenues while advancing the core AI engine. **AI Materials Science:** Already discovering thousands of new materials that could dramatically improve batteries, semiconductors, and other hardware across all ventures—feeding back into better TPUs and infrastructure. ## The Compounding Network Effects **Data Flywheel:** More users → More training data → Better AI models → Better products → More users. AI Overviews now drive 10%+ more queries for the types of searches that show them. **Revenue Flywheel:** AI success → Higher cloud/advertising revenue → More R&D investment → Better AI → Market expansion. Google Cloud's 32% growth funds continued AI leadership. **Talent Flywheel:** Best AI infrastructure → Attracts top researchers → Better models → More ambitious projects → Attracts even better talent. The recent $2.4B Windsurf acquisition shows Alphabet winning the talent war. **Infrastructure Flywheel:** More AI demand → Larger TPU deployments → Better hardware optimization → Lower costs → More competitive offerings → More demand. **Ecosystem Lock-in:** AI features across Gmail, Docs, YouTube, Search, and Android create switching costs that compound across products. Users don't just leave Google Search—they'd have to abandon their entire digital workflow. ## The Strategic Moat Widens While competitors excel in individual areas, Alphabet's advantage comes from **deep integration creating compound effects**: - **Capital Moat:** The $85B capex commitment (13% increase from 2024) exceeds most competitors' total revenues - **Integration Moat:** OpenAI using Google TPUs despite being competitors proves the hardware-software integration is unmatched - **Scale Moat:** 2+ billion AI Overview users and $50B+ cloud run rate create network effects competitors can't replicate - **Ecosystem Moat:** AI embedded across Search, Gmail, YouTube, Android, Chrome, and Workspace creates compounding switching costs - **Innovation Velocity:** Time from AI research to deployed products at billion-user scale continues compressing ## The Key Insight The Q2 earnings reveal that Alphabet isn't just building an AI company—**they're building the infrastructure that accelerates invention itself**. Each breakthrough feeds back into the system: new discoveries generate revenue that funds more research, create better tools for the next breakthrough, and attract top talent. More importantly, they're embedding AI so deeply into users' daily workflows—from Gmail to YouTube to Search—that switching becomes not just inconvenient but practically impossible. When your email, documents, entertainment, and information all work seamlessly together through AI, why would you ever leave? The $85 billion capex increase signals management's confidence that they're approaching "escape velocity"—where their innovation rate becomes impossible for competitors to match. While others debate AI spending, Alphabet is already demonstrating profitable AI deployment at unprecedented scale while simultaneously investing in the next acceleration phase. **The Bottom Line:** Alphabet's integrated flywheel of AI research, proprietary hardware, massive data, and patient capital is creating an innovation velocity that competitors are finding increasingly difficult to match. But their true moat is embedding AI so deeply into billions of users' daily habits that the entire Google ecosystem becomes indispensable—and the Q2 results prove this strategy is already working.
NASDAQ:GOOGLong
by rathernotsay21
What the Market Is Telling Us About Altcoin Season in 2025Altcoin season is that highly anticipated market phase where alternative cryptocurrencies outperform Bitcoin and dominate trading activity. As we move through 2025, several key signals suggest we may be entering just such a phase—and investors are paying close attention. Key Market Indicators Bitcoin dominance is falling below 50–52%, historically a sign of capital rotation into altcoins. Trading volumes are spiking in Ethereum, Solana, Chainlink, Toncoin, and others. Sector-specific excitement is building around Web3, AI tokens, and decentralized physical infrastructure (DePIN). While this might be just the early stage of the altcoin cycle, the smart money is already positioning. Investor Considerations Focus on projects with real fundamentals. Ethereum, Avalanche, Cosmos, and Chainlink remain top infrastructure bets. Utility is key. Projects with real-world application, strong developer activity, and growing user bases are best positioned for long-term growth. Track sentiment. Watch for social buzz, news momentum, and open interest increases—often the earliest signs of breakout moves. Bottom Line Altcoin season doesn’t happen overnight. What we’re seeing now is the accumulation phase—an ideal time for data-driven investors to build high-upside portfolios. But caution is critical. Not every pump is sustainable, and smart risk management remains non-negotiable. For those who prepare wisely, the 2025 altcoin season could unlock some of the most lucrative opportunities in the crypto space.
MEXC:ALTCOINUSDT.P
by HCN-News12
Leslies Inc | LESL | Long at $0.41**VERY risky trade - 25% or more risk of bankruptcy** Leslies NASDAQ:LESL is a direct-to-consumer pool and spa care brand in the U.S., selling chemicals, equipment, and services. The stock dropped 88.86% last year due to weak demand, flat revenue, shrinking gross margins from stock write-downs, higher rent, shipping costs, and an earnings miss (-$0.25 vs. -$0.244). High debt, market share losses to e-commerce, and a competitive pool supply market also contributed. On a positive note, the company generated $1.33 billion in revenue for fiscal year 2024. New leadership has entered the picture, cost-cutting is starting to happen, and summer season may boost pool sales. While 2025 is still projected to be a rough year, revenue is forecasted to grow 6.4% in 2026 and 2027 and earnings are likely to turn positive (based on company statements). While this is a *highly risky* play and there are absolutely better companies out there, I think there is a chance this ticker may get some steam in the near future. 7% short interest, 176 million float. Thus, at $0.41, NASDAQ:LESL is in a personal buy zone. Targets into 2027: $1.00 (+143.9%) $2.00 (+387.8%)
NASDAQ:LESLLong
by WorthlessViews
A BNPL Bubble Is Actually Why I'm Bullish, For NowBNPL is growing and inflating at an increasing rate. From concert tickets to burritos, everyone is using buy now pay later. The global market is projected to hit 560 billion dollars in 2025, up from around 492 billion in 2024, and climb to 912 billion by 2030 at a compounding growth rate of 10.2%. Just in the U.S. alone, demand is expected to reach 122 billion next year and scale to 184 billion by the end of the decade. The trajectory is steep, with the structural weaknesses already showing. Block is positioned at the center of BNPL. In Q1 2025 they reported: 2.29 billion in gross profit, up 9 percent YoY 466 million in adjusted operating income, up 28% 10.3 billion in GMV through Afterpay, with 298 million in BNPL gross profit, up 23% YoY The stock took a hit. It dropped 9 percent in February and another 21 percent after missing Q1 earnings, but this is seen as typical early bubble behavior. There is short term fear but continuing growth and acceleration. Klarna’s credit losses, IPO delays, and regulatory friction are not problems, they are actually signals that the sector is growing faster than the market, or quite frankly, anyone can control. BNPL is becoming the default credit system for younger consumers. It is overused and expanding too fast. That is the formula for both upside and implosion. However with that, timing will be everything here, and knowing when to close will be crucial if BNPL can't stabilize. Baseline expectation: SQ trades in the 80 to 90 range in the short term Midterm upside: 120 by 2027 Long-term target: 180 to 220 if BNPL stabilizes and Block captures its runway
NYSE:XYZLong
by chrisapach
1
Braxons Group: How Cryptocurrency Became Part of Everyday SpendiOver the past five years, cryptocurrency has gradually moved beyond the narrow confines of a speculative asset toward what it was meant to be from the start — a fully functional means of payment. In July 2025, a study by Bitget Wallet confirmed a significant shift in consumer behavior: millions of users worldwide now use digital assets to pay for goods, games, and travel. Braxons Group analysts see this not just as a trend, but as a clear sign that crypto is entering a mass-adoption maturity phase. Crypto in Shopping: From Enthusiasts to Households According to the study, 35% of users now use cryptocurrency for everyday purchases — not only for digital goods, but also for paying for food, services, and essential products. Braxons Group notes a sharp rise in crypto payment integration with POS terminals and online marketplaces, especially in Southeast Asia, where digital wallets often replace bank cards. The growth is driven by low fees, lack of bank control, and instant settlements — particularly via USDT and BUSD. Gaming: The Key Engagement Driver 36% of users regularly use cryptocurrency for in-game purchases and Web3 applications. This comes as no surprise: NFT items, premium memberships, and tokenized game assets are now core components of most gaming economies. Braxons Group highlights that Gen Z and millennials form the backbone of this new crypto audience. Their willingness to spend tokens on in-game content demonstrates high adaptability and low entry barriers. This is an important investment signal: companies operating at the intersection of crypto and gaming will likely become dominant growth drivers over the next 3–5 years. ✈ Travel: Crypto Crosses Borders Around 35% of respondents use cryptocurrency for booking tickets, hotels, and travel services. For Braxons Group, this validates the hypothesis that crypto is the ideal tool for global users — eliminating currency restrictions, reducing banking fees, and enabling direct bookings without intermediaries. Among older demographics (Gen X), trust in crypto for high-value transactions is increasing. This marks a shift in the market: a sector once dominated by speculation is now becoming practically useful for everyday needs. Regional Differences The Bitget study revealed notable geographic patterns: Southeast Asia — leader in everyday crypto payments (up to 41%) Africa — active use for education payments Latin America — strong e-commerce adoption (up to 38%) Middle East — growing interest in high-ticket purchases (cars, tech, luxury goods) For Braxons Group, this means the decentralized payments market is becoming multi-layered and globally fragmented, requiring region-specific solutions. Braxons Group’s Conclusion Our team concludes that cryptocurrency is evolving from an investment class into a transactional tool. It no longer makes sense to view digital assets solely as a store of value or speculative vehicle. What was once an experiment is now daily reality: Gamers buy NFTs and passes with tokens. Households purchase groceries with stablecoins. Travelers book accommodation with ETH. The next step? Integrating cryptocurrency into banking and government systems. For businesses, this means embedding crypto infrastructure is now a must-have for digital competitiveness.
OKX:BTCUSD
by CryptoLifeone
ROIV: A Speculative Biotech Play with Cash in the Bank and CatalRoivant Sciences (NASDAQ: NASDAQ:ROIV ) is one of the more intriguing speculative plays in the biotech sector right now. Trading around $11.45, the stock offers exposure to a deep pipeline of clinical-stage assets through its decentralized “Vant” model—subsidiaries focused on specific therapeutic areas like Immunovant (autoimmune), Pulmovant (pulmonary), and Priovant (inflammatory and dermatological conditions). The company went public via SPAC in 2021 and has maintained a capital-efficient approach, acquiring and spinning off promising drug candidates. What sets Roivant apart is its incredibly strong balance sheet: nearly $5 billion in cash and equivalents with minimal debt. That translates to about $7 per share in net cash, giving it one of the strongest financial positions in the biotech sector and a long operational runway. Roivant’s upcoming earnings call on August 7 (after market close) will be closely watched. Investors are particularly focused on late-stage clinical data expected in the second half of the year, including Phase III readouts for brepocitinib (Priovant) and updates from Immunovant’s FcRn inhibitor programs. These results could serve as major price catalysts. Financially, Roivant is still burning cash, as expected at this stage. The most recent quarterly earnings showed an EPS loss of –$0.29, missing analyst expectations. Revenue came in at $7.6 million—above estimates but significantly below the prior year’s figure of $28.9 million. Free cash flow was –$844 million for the year, but with a current ratio over 30 and a healthy reserve, the company is in no danger of running out of capital in the near term. Technical Outlook: Holding Range, Eyes on Breakout The daily chart shows ROIV in a tight $10.80–$11.80 range, consolidating after a solid run. While the short-term 15-min chart showed a recent pullback, support held at $11.40 and triggered a fresh entry signal in our system. MACD is flattening and could curl bullish again soon. On the daily, MACD remains bullish with room to run if volume enters. A break above $11.70–$11.80 could trigger the next leg toward $12+, and ultimately the psychological and options-heavy $13 level. Options Activity: Big Bet on October $13 Calls What’s catching serious attention is unusual options flow on the October $13 call contracts. Over 17,000 contracts are open, with recent trades in the $0.45–$0.55 range—showing real speculative interest in a move above $13 by Q4. That’s about a 13% move from current levels, well within range for biotech on a good catalyst. I like the $12 August call for ROIV offers a more conservative upside play than the $13 strike, with less distance to break-even and still attractive risk/reward. Trading around $0.20–$0.25, it only requires an ~5% move to be in the money, making it a more realistic target if momentum builds post-earnings or on positive trial news. With less premium risk and higher probability, it’s a smart middle ground. And it's not a bad buy at $12 heading into Q4. My Position I’ve taken a very small position in near-term calls to test the setup and stay engaged. The combination of: A strong cash runway Upcoming catalysts Technical setup near breakout And rising options interest makes ROIV a name to watch closely. The Setup: Binary Risk, Asymmetrical Reward For those considering the October contracts, this is a classic biotech setup: Defined risk (premium paid) Asymmetrical upside if catalysts hit A clear breakout level to monitor ($13+) And a high cash floor that provides downside cushion This fits perfectly into a broader strategy of small speculative bets with high return potential. Roivant isn’t without risk—trial results and sentiment shifts matter—but it’s one of the better-positioned clinical-stage plays heading into the second half of 2025. Watch for updates on Priovant and Immunovant, track the $13 level, and monitor volume and MACD crossovers for clues. If this stock breaks out, October could be the window.
NASDAQ:ROIV
by seed
Small cap is the flavor of the day - Long at 4.05I decided to do a small cap stock today. I don't use too many of these as ideas, though I do trade them on my own. I don't usually publish about them because they are inherently more risky than large cap, established stocks. And to be fair, RBBN has a spotty history from a chart perspective. Go ahead and zoom on out all the way. See that? That's what danger looks like. This stock has lost 80% of its value in the last 10 years, and 50% in the last 4. However, in its defense, it is profitable on a reported earnings basis over the last 12 months, and has held its own for several years now, and that's why I'm not AS nervous as I might otherwise be publishing this. Additionally, it's solidly above its 200MA and in both a 1 year and 2 month uptrend, so its recent strength is good. I haven't dug down all the way back to its debut, but I suspect I'd have at the very least had a challenge making money on this one over its entire existence. But I am not trading its entire existence today. 75% of the trades in this stock in the last year would have closed in under 2 weeks, so the short term picture is what I'm mostly looking at here, and over the last month or so this has been a very solid stock. Could that change tomorrow? Yup. But I don't have that crystal ball. All I can do is rely on the system that has of late produced excellent results here. In the last 12 months, there have been 27 buy signals here. 25 closed profitably and 2 are still open and down 18% and 9%, respectively. INCLUDING the losers, however, the median daily return on those trades has been .48% (>10x the market avg) and the average daily return is 1.02% (> 23x the avg daily market return). Trading is about balancing risks and rewards. This stock is riskier than most, but the rewards are a lot better, too. I don't put all my money into any one trade - that's a TERRIBLE idea. The vast majority of my open trades are relatively safe, large cap stocks. But risky has its place in a portfolio. I made 15% in 2 days recently on QUBT (I posted that trade here) and made almost 18% on NUTX in the last 2 days - just closed that trade today. As a % of my portfolio of trades, ones like that can be small positions, but make a meaningful impact. That's my hope for RBBN here. Of the 25 winning trades in the last year, over half produced a gain of 4% or more. And the average holding periods of the winners was only 8 days, with 15 of the 25 closing in a week or less. That rapid return also reduces the risk in a stock like this one. Wnen you only stick around for a few days most of the time, it's harder (not impossible) to get caught holding the bag during a drop. My close will be signal based, and not a particular price target, but the trades I referred to above on RBBN give a good outline. However, the 2 losers have been open since February, so be forewarned that IF you follow me on this one, you might need to buckle your chinstrap. It could get bumpy. As always - this is intended as "edutainment" and my perspective on what I am or would be doing and why, not a recommendation for you to buy or sell. Act accordingly and invest at your own risk. DYOR and only make investments that make good financial sense for you in your current situation.
NASDAQ:RBBNLong
by redwingcoach
(Learn More)Use These 3 Steps To Spot Long-Lasting Trends👉Trade before the earnings report 👉Make sure the volume oscillator is below zero 👉Make sure the MACD lines give you a Bullish signal If you look at this chart you can see all the steps alignment. This is very important because you want to catch a long term trend. Also it has to follow the 3step rocket booster strategy. In order for you to learn more about this strategy 🚀 Rocket Boost This Content. Disclaimer ⚠️ Trading is risky please learn how to use Risk Management And Profit Taking Strategies. Also feel free to use a simulation trading account before you use real money.
NASDAQ:TSLALong
by lubosi
Waste Management confluencesFirst of all fundamentally the company is basically essential to our survival so I have no reason to believe they will go out of business any time soon. Earnings report soon should bring about some volatility. I was foolish enough to buy the top a couple months ago and deciding today I will add the the position because I like this price. Even though I bought the top, it was still below the intrinsic value at the time so it was a reasonable decision. With my simple trendline and rudimentary use of a Fibonacci I am able to set a price target of $260 depicted by my drawing of a potential new leg up. This is backed up by the absolutely fundamental usage of a calculation of the intrinsic value, which by my calculation is $280, and has a range between $170-$640 however these numbers may need to be adjusted after the earnings report. The value is now well below the intrinsic value so I am seeing this stock as a really good deal now. Despite any uncertainty in the economy Waste Management has seemed to outperform during these times so it is in my portfolio defensively. This stock is strong when it needs to be, which is why I like it.
NYSE:WMLong
by Capitalist_Zach
$HBAN - well positioned to continue on its pathNASDAQ:HBAN has been in a rising channel since April, and is no touching the lower band of the channel. His area also includes some previous resistance turned support, as well as some movement paces. NASDAQ:HBAN recently announced they are acquiring Veritex ( NASDAQ:VBTX ) which will strengthen their mark in Texas. Please note NASDAQ:HBAN is releasing earnings July 18th. A good report should see the stock moving towards the upper band of the channel, maybe break through it.
NASDAQ:HBANLong
by WeRideAtDawn
Double Calendar Option Spread on MMMUsing a double calendar spread to profit from price movement in either direction after earnings announcement in 3 days time (18 July) for MMM. These trades can be extremely profitable if one expects movement after earnings. Selling both a Put and Call at high (pre-earnings IV) makes this option trade relatively cheap, since the purchase for the other Call and Puts are after earnings announcement with lower IV Selling a Call with Strike $167 for 18th July Selling a Put with Strike $145 for 18th July Buying a Call with Strike $175 for 29 Aug Buying a Put with Strike $140 fro 29 Aug Total net debit and max loss $125 for 1 contract Max profit $ 287 For more details on these type of Option trades you can search for Strategic Options Trader on Substack
NYSE:MMM
by delden1
“How Other People’s Fear Becomes Our Profit”From a behavioral and technical standpoint, LEVI presents a textbook short opportunity following its post-earnings overreaction. After a strong earnings beat, the stock surged over 13% intraday, reaching a high of $22.07. However, this rally quickly pushed RSI into overbought territory, triggering natural selling pressure. Much of this sell-off can be attributed to traders who previously bought near the $21–$22 range and are now looking to exit at breakeven—a classic example of loss aversion and anchoring bias. This emotional response often leads to temporary price spikes followed by sharp corrections. We are now observing that exact pattern, with the stock fading to $21.92 in after-hours and closing at $21.95, signaling buyer exhaustion. Technically, this marks a short-term trend reversal—from bullish earnings momentum to a developing downtrend. The price action shows rejection at key resistance, weakening volume, and emotional exit zones being triggered. Now is a clean, high-probability shorting opportunity, with potential to capture 2–7% downside in the next 1–2 sessions, especially as the broader market reacts to inflated valuations and profit-taking behavior.
NYSE:LEVIShort
by ChartKings
1